Objective Active surveillance (AS) allows men with favorable-risk prostate cancer to avoid or postpone active treatment and hence spares potential adverse effects for a significant proportion of these patients. Active surveillance may create an additional emotional burden for these patients.
difficulties in quality of life (QoL) or psychological well-being. However, this review used narrow inclusion and exclusion criteria and excluded studies referring to Watchful Waiting (WW), a management approach that is palliative in nature but often incorrectly used interchangeably with AS. This omission may have led to the exclusion of some relevant papers. The lack of critical appraisal meant study quality was not taken into consideration in the interpretation of the results.
In a similar quantitative review, 6 it was concluded that AS was unlikely to be associated with an adverse effect on general psychological well-being. In this instance, studies describing WW or "no treatment" were included. However, no distinction was made between those studies describing AS versus true WW. Although the methodological quality of studies was assessed, this was not considered when interpreting the results of the review. In addition, neither of these reviews included qualitative studies, which meant that an important opportunity to better understand the experiences of patients was missed. It is our contention that a mixed-methods (MM) review that includes both qualitative and quantitative studies would allow for richer experiential data to be included without compromising generalizability achieved using quantitative methods. 7 
| AIMS
The aim of this systematic mixed studies review was to synthesize and appraise the quantitative and qualitative knowledge to develop a more comprehensive picture of published studies reporting the psychological impact of undergoing AS.
| EVIDENCE ACQUISITION
The Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines were used for the conduct and reporting of this systematic review. 8 
| Eligibility criteria
Inclusion criterion was noninterventional studies published in English assessing the psychological impact of AS in lower-risk PCa, including studies comparing AS with AT. Studies referring to WW were included when the definition was that of AS.
Exclusion criteria were review articles, editorials, comments, intervention studies (eg, studies that included a psychosocial intervention), needs assessments, and studies assessing QoL. While QoL is an important factor, it was deemed inappropriate for the present review because of the insensitivity of general QoL measures in assessing clinical change in psychological functioning. 
| Information sources
Medical and nursing databases were searched from inception between August and September 2015 with no limitations on time, using a predetermined search strategy ( Figure 1 ). Titles and abstracts were screened by E.R. and G.P. based on the inclusion/exclusion criteria;
where there was doubt regarding the eligibility of a particular title or abstract, the record was retained for full-text screening. O.S. arbitrated
any disagreement at the full-text screening stage.
| Study selection
Qualitative and quantitative findings related to the prevalence and predictive/protective factors of psychological variables were reported, namely, depression, anxiety, and uncertainty. E.R. and G.P. extracted data from each article and applied the quality appraisal tool, and O.S.
arbitrated any disagreement.
| Data collection process
The Mixed Methods Appraisal Tool (MMAT), 10 an appropriate, reliable, and efficient tool for mixed studies reviews, was used to assess study quality. 11 E.R. and G.P. completed the MMAT for each study, with O.S.
arbitrating. This appraisal directly informed the interpretation of study findings.
4 | RESULTS 
| Synthesis of results

| Quality appraisal
Using the MMAT, 11 papers were scored against 4 main criteria associated with the specific research design; 4 papers met 100% of criteria;
15 met 50% to 75%; and 4 met only 25% of the methodological quality criteria (Table 1) . Failure to justify sample size, inappropriate/no comparison group, and lack of baseline measures were the most frequently observed methodological issues.
| Depression
Twelve quantitative studies investigated depression in this population, reporting data for 1007 AS patients in total. Five studies included AT men as a comparison group. 14,15,18,23,26 Six different scales were used to assess depression (Table 2 ).
| Quality appraisal
Eight of the 12 studies were considered high-quality studies (75%-100% of methodological criteria were met). Two of the studies fulfilled 50% of the methodological criteria 15, 22 ; with an insufficient response rate, failure to provide reasons for nonparticipation and an inability to determine if the sample was representative because of the authors failing to report demographic information per treatment group included were limitations of these studies. Two studies met only 25%
of the methodological quality criteria. 16, 29 The first 16 failed to justify sample size, provide reasons for nonparticipation, and recruit from support groups, leading to a potential selection bias. Response rate was also not reported. 16 In the second, 29 the Hospital and Anxiety
Depression Scale was used inappropriately to diagnose clinical depression. Hospital and Anxiety Depression Scale does not include somatic symptoms that make up the diagnostic criteria of clinical depression; therefore, the measure used does not address the aims of their study.
Other methodological issues included lack of a representative sample, because despite the use of multiple sites, 95% of the sample identified as white British. The authors' failure to include a control group also reduced the MMAT score attributed to the study. The study did however include a large number of participants (n = 313), and their response rate was high (73.47%).
| Prevalence
Four studies reported prevalence data for depression. 14, 21, 25, 29 Generally, the prevalence of depression was low; 2 studies reported mild depression ranging from 4% to 11%, 14, 21 with moderate-severe depression reported in less than 5% of both AS and radical prostatectomy patients. 21 One study reported clinically significant depression in 12.5% of their sample. 29 There was disagreement regarding the severity of depression in comparison with that in noncancer men. One study reported that although mild, depression score was higher than literature reporting depression scores for men without a PCa diagnosis. 14 Conversely, depression levels were reportedly similar to normative data of clinical populations. 25 However, the latter study used a prospective, longitudinal design, with low attrition rates, therefore reducing the impact of individual differences and increasing credibility of the findings. When compared with curative treatment patients, AS patients had the most favorable depression score. 15, 26 Although the difference between AS and radical prostatectomy patients immediately postdiagnosis/early treatment was statistically significant, clinical significance was not reported.
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One low-quality study 29 reported a higher number of participants scoring within clinical levels; although the mean score of depression was low, 12.5% of patients' scores suggested presence of clinical depression.
| Factors associated with depression
Five studies attempted to identify factors predicting depression (Table 3) . Neurotic patients who experienced a major life event additional to their diagnosis demonstrated increased depression. 24 Extraversion, continued sexual activity, and higher QoL were associated with decreased depression. 24 Similarly, patients with higher QoL and low neuroticism reported lower depression at diagnosis. 25 It was concluded that patient-bound factors, eg, personality, were the most important determinants of depressive symptoms. 13, 15, 24 Lack of a partner and impaired mental health (MH) were both predictive of poorer well-being. 13 Patients enrolled in AS protocols soon after diagnosis were more likely to adopt poor coping strategies and demonstrate maladaptive adjustment to cancer; these patients had less time to seek information to support their choice of AS and therefore understand that their PCa was manageable. and no standardized tool for assessment of anxiety. 18 Three studies met 25% of the methodological quality criteria 16, 28, 29 ; issues with these studies included low sample size, potential selection bias, insufficient response rate or failure to report the response rate, reasons for nonparticipation not explained, failure to include a control group, and inappropriately timed baseline measurements.
| Prevalence
The prevalence of anxiety ranged from 13% to 45%. 12, 14, 21, 22, 24, 25, 27, 29, 30 One study reported up to 5% of patients with moderate-severe anxiety levels, 21 and 1 with almost 25% of participants with clinical levels of anxiety. 29 The majority of studies reported anxiety comparable or lower than data from nonclinical populations. 12, 14, 22, 24 One study 21 reported that the majority of participants had anxiety higher than that of noncancer men; however, the study cited to support these claims included no noncancer data. 35 The AS men appeared to have low anxiety when compared with patients opting for AT. 15 Only 1 study directly contradicted these find-
; however this can be attributed to potential selection bias in the increased psychological dysfunction reported by those completing follow-up.
| Change in anxiety over time
Six studies examined the temporal variability in anxiety. [19] [20] [21] [25] [26] [27] With the exception of 1 study, 25 statistically significant declines were observed over time. However, the 1 contradictory study 25 was of high methodological quality and maintained a high response rate during study follow-up. One study reported that although 20% of patients suffered from clinically significant anxiety levels at baseline (within 6 mo of diagnosis), only 5% of the total sample chose to leave the AS protocol because of the psychological burden. 27 A significant decrease was observed in general anxiety and fear of disease progression over the course of the 18-month follow-up. 27 A number of other studies support these findings, also concluding that anxiety remained either stable or reduced over time. 15, 20, 23, 24, 26 In a 30-month follow-up study, 19 anxiety reduced significantly at 18 and 30 months postdiagnosis. Interestingly, 12-and 24-month follow-up data were not significant; typically, this is when patients receive a biopsy to reassess their cancer and resulting course of treatment, although it must be noted that the trend of declining anxiety remained consistent across these time points.
Longitudinal studies documenting a general decline in anxiety during AS are supported by 2 of the 3 cross-sectional studies that asked men to report number of months spent on AS. 14, 21, 24 Although not significant, increased time undergoing AS was associated with stable or decreased anxiety. 22, 24 One cross-sectional study however found a significant increase in anxiety with reported increased time since diagnosis. 14 Individual differences are an important factor, and cross-sectional studies must be interpreted with caution despite apparent high methodological quality; this study design may simply not be appropriate to capture these men's experiences. On the basis of the results of the previously reported high-quality study 19 (Table 1) , anxiety appeared to fluctuate therefore the time point at which the cross-sectional studies assess men would be crucial in terms of the anxiety reported and may explain some of the conflicting results discussed.
| Factors associated with anxiety
The factors that appeared to be predictive of anxiety were as follows: high neuroticism 24 ; younger age at diagnosis 14 (Table 3) . With the findings in relation to decreased number of cores taken at diagnostic biopsy, the authors suggested that this may be a result of the patients' perception, however inaccurate, that more of their cancer had been removed. 13 High neuroticism and high PSA were associated with increased PCa-specific anxiety. 24 Fear of disease progression, a component of PCa-specific anxiety, was identified as a trigger for discontinuation of AS in favor of AT. 19 The combination of high QoL and low neuroticism was reported to be significant in minimizing anxiety. 25 
| Uncertainty
Six studies assessed uncertainty in 266 AS men. Three studies were qualitative 32-34 and 3 quantitative. 17, 19, 28 The quantitative studies used the Mishel Uncertainty in Illness Scale (Table 2 ) to measure uncertainty. Four additional papers were included in the uncertainty theme because of their assessment of decisional conflict, 16, 24 ,25,27 a state of uncertainty, using the Decisional Conflict Scale (Table 2) .
One study included a comparison group of Irish and North American AS patients. 
| Quality appraisal
Of the 10 studies assessing uncertainty in the AS population, only 1 met 100% of the methodological quality criteria in the MMAT. 24 Three studies met 75% of the criteria 19, 25, 27 -the absence of a comparison group in 2 of these studies prevented them from meeting all the methodological quality criteria 25, 27 -whereas potential selection bias in the recruitment of participants was an issue in the third study. 19 One qualitative study 32 also met 75% of the methodological criteria, as a result of failing to acknowledge their influence on their data. The 2 remaining qualitative studies 33, 34 met 50% of the methodological quality criteria because of the lack of acknowledgement of the researchers' influence and the impact that the context within which the research took place had upon the participants and resulting data. Two quantitative studies also met just 25% of the methodological criteria 16, 28 ; failure to discuss the justification for their specific sample size, reasons for potential participants' nonparticipation, response rate, and issues with sampling were the reasons for this. Finally, 1 additional paper met only 25% of the methodological criteria 17 ; this was due to the small sample (n = 29 participants), failure to apply appropriate inferential statistics as a result, and a failure to report the response rate.
| Prevalence
None of the included studies reported the prevalence of clinically significant uncertainty using the Mishel Uncertainty in Illness Scale. However, approximately 25% of patients scored clinical levels in Decisional Conflict Scale. 24 ,25,27
| The perception of uncertainty
The 3 qualitative studies included in this review identified similar themes regarding the nature of uncertainty experienced during AS, which contrasted with the quantitative findings. Men described "intolerable uncertainty" a "dangerous wait," characterized by uncertainty and a perception of "risking one's life," 33 although this study included only those who had converted to AT, which may overstate the impact of uncertainty in AS. The other qualitative studies interviewed men who remained on AS. 32, 34 The theme "To be Uncertain, Afraid, Worried" emerged in one of these qualitative studies 32 in participants still undergoing AS with respondents describing constant threat, fear, and worry.
While patients understood the information about their diagnosis and prognosis intellectually, they had not integrated the message emotionally. 32 An overarching theme of uncertainty prevailed in each participant's account, either implicitly or explicitly. 32 This theme was characterized similarly to those previously reported: persistent uncertainty surrounding mortality and potential spreading, potential need for AT, and patients' ability to cope with treatment-induced morbidities. Participants described living in "shadowland" while they "waited for a disaster". 32 These subthemes were related back to patients' masculine identities: pressure to maintain sexual function and to continue to provide financial stability for their families. 34 Participants qualitatively described uncertainty as featuring more significantly throughout the AS experience than the quantitative data suggested, a finding warranting further study.
| Change in uncertainty over time
Three of the included uncertainty studies assessed uncertainty longitudinally. 19 ,25,27 Attrition was generally low at initial follow-up points, with response rates >70% 19, 25, 27 ; however, response rate dropped to 67% 27 after the 18-month follow-up and 44% after the 2-year follow-up. 19 Uncertainty decreased from baseline to 18 months; however, this decrease was neither statistically nor clinically significant. 27 Uncertainty at 6 months postdiagnosis predicted scores after 9 months of AS, suggesting that uncertainty remains stable within the first year.
A significant decrease was found from baseline up to 30 months postdiagnosis 19 ; however, attrition may have been an issue. Conversely, patients qualitatively reported that uncertainty was timesensitive and peaked leading up to monitoring appointments, PSA and biopsy results. 34 
| Factors associated with uncertainty
A number of factors were reported to increase uncertainty, including high neuroticism and increased role of clinician in decision making. 24, 25 Patients who experienced depression and had a more negative outlook were less satisfied with their treatment decision 16 (Table 3) .
Uncertainty was reported to be a significant factor and had a resulting impact on QoL and fear of disease progression. 19, 28 It was reported that it was the perception of danger associated with AS that increased uncertainty and had the resultant impact on QoL. 28 Anxiety was also associated with uncertainty. 28 Factors reported to decrease uncertainty and decisional conflict were also discussed in the literature: High extraversion and the management of PCa in a university/specialist hospital appeared to be associated with lower decisional conflict. 24, 25 Palpable disease and older age at diagnosis reportedly had an additional favorable effect on the perceived risk of progression, a form of uncertainty, at follow-up.
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The finding in relation to palpable disease appears to be counterintuitive; the authors posited that older patients with palpable disease at diagnosis may experience higher uncertainty initially yet, following a period of time on surveillance, shows greater improvement upon realizing the feasibility of surveillance. 25 Favorable MH, optimism and higher self-efficacy, and perceived consistency in medical information were associated with reduced uncertainty. 16 Qualitative data suggested that stable or decreased disease characteristics at follow-up reduced uncertainty surrounding impending follow-up appointments and delays between monitoring appointments and receipt of results. 34 Patients also discussed feeling more secure when they saw the same clinician at follow-up appointments. 34 The role of clinicians was ambiguous. They were sources both of uncertainty in that they were potentially bearers of bad news that the cancer had progressed further and of security in that they provided patients with the reassurance of regular checkups.
32
Patients appeared to cope with uncertainty and decisional conflict in various ways, as was described in 2 qualitative studies. 32, 34 With regard to decision making, patients appeared to assume either a passive or active role in the process, some patients opted to defer to decision-making power entirely to their clinician, and others chose to actively seek out further information or request a second opinion to engage more with the decision-making process. 32 Similarly, in response to diagnosis, some patients reported that they decided to "screen off" their cancer by setting aside feelings of threat or completely denying the existence of their cancer, while others compensated for the perceived threat of their cancer via lifestyle change. 32 Patients also described control as central to their coping; this control was asserted by "living a normal life," 34 similar to "screening off," 32 or
by "doing something extra," a theme that also coincides with lifestyle change discussed previously. Specifically, a lack of appropriate comparison/control groups, and unavailability of baseline data, leads to an inability to determine if men who choose AS are fundamentally less anxious than those who opt for immediate AT. Although potential predictors of adverse psychological adjustment were identified, these methodological limitations reduce confidence that they fully captured the experience of these men; therefore, resulting implications for practice must also be treated cautiously. This lack of confidence is reinforced by conflicting results emanating from different research designs. Particularly pertinent were differences in results relating to anxiety and depression between cross-sectional and longitudinal studies. It must be noted that although levels of anxiety and depression appeared to resolve over time when patients were followed up longitudinally, attrition and response rate must be considered when evaluating the strength of the evidence. This is reflected in 1 study 25 that contradicted other longitudinal studies that reported decreasing anxiety and depression at later follow-up points; the same study had one of the lowest rates of attrition with an 84% response rate. This highlights the importance of reporting reasons for nonresponse and analysis of potential sociodemographic differences between complete and incomplete responders.
As well as different findings resulting from longitudinal and crosssectional evidence, further differences were observed in relation to qualitative and quantitative uncertainty data. In terms of prevalence, quantitative studies indicated that uncertainty appears to be low in this population. However, when the nature of uncertainty was explored in qualitative studies, it appears to have a more significant impact on men than is reflected in the quantitative data. This idea is comparable with how QoL is conceptualized in the severity of symptoms versus the "bother"/impact that is experienced by the patient as a result; ie, the impact of uncertainty on the individual cannot be ignored. Because no qualitative studies reported on anxiety or depression, potential differences in these areas remain moot, requiring further investigation.
| Limitations of the included studies
Some questions need to be raised in relation to the comparators chosen in the reviewed studies. This is a significant issue because it is only through comparison that the extent of difficulties, or perhaps lack thereof, can be fully understood. Several studies included patients opting for AT as comparators, while others compared their results with reference values. Arguably, a more appropriate comparison is agematched men with no PCa diagnosis in addition to patients opting for AT. Because of the high incidence of undiagnosed lower-risk PCa in men older than 60 years, 36 it can be extrapolated that the psychological differences between patients and age-matched volunteers would be attributable to PCa, and the AS experience.
A further criticism of the studies was that, because the patients sampled had already selected AS as a treatment course, it is possible that patients who were naturally less anxious, depressed, or uncertain chose AS because of increased ability to cope. One study that attempted to assess selection bias 21 observed that participants who completed follow-up reported greater psychological dysfunction than those lost to follow-up, illustrating an additional potential bias in terms of the type of patient that remains involved in psychological studies.
None of the studies used an MM design and only a limited number were qualitative, and these only reported results for uncertainty. This is limiting in that men on AS are not being afforded the opportunity to express their interpretation of their experiences. The MM research would be of particular benefit in this area, maintaining generalizability while still providing an opportunity to gain a deeper understanding of patients' experiences of AS and PCa generally. 7 The value of this approach is illustrated in men's description of uncertainty. In qualitative studies, participants described overwhelming uncertainty that continued throughout AS, [32] [33] [34] whereas in quantitative studies, uncertainty reportedly decreased over time. This discrepancy warrants further exploration. This review returned no qualitative papers relating to anxiety or depression; a qualitative study examining these outcomes may have presented different findings, as was the case with uncertainty.
| Limitations of the review
Because of the absence of universal measures for each psychological dimension studied, and indeed consistency in the definitions of each psychological dimension, eg, interchangeable use of the terms distress and depression, it was not possible to combine the data of multiple quantitative studies in a meta-analysis. Because of the small number of qualitative studies included, a meta-synthesis was also not feasible.
Although attempts were made to minimize the impact of the use of varying terminology for the process of AS, by using multiple terms in the search strategy (Figure 1 ), it remains a possibility that studies using different terminologies for AS/studies failing to provide sufficient definitions for the management program assessed were not retrieved.
The papers included in this review were also checked against those studies included in previous systematic reviews 5, 6 ; neither review uncovered additional papers, aside from those discussed as limitations previously, ie, inclusion of WW papers. This review was completed for part-fulfillment of E.R.'s PhD. No outside funding was used.
| Recommendations for future research
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